Valtecne SpA

Valtecne SpA EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Valtecne SpA (VLT.MI) as of Oct 23, 2026 is 4.91 M EUR. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 6.19 M EUR — a change of -20.65% (lower).

EBITDA

4.91 MEUR

YoY

-20.65%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Valtecne SpA is 2025 4.91 M EUR. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Valtecne SpA was 2024 6.19 M EUR. It decreases by -20.65% lower compared to the previous year.

The Valtecne SpA EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2019
2.88 M EUR
Jan 1, 2020
1.52 M EUR
Jan 1, 2021
2.87 M EUR
Jan 1, 2022
4.26 M EUR
Jan 1, 2023
5.80 M EUR
Jan 1, 2024
6.19 M EUR
Jan 1, 2025
4.91 M EUR
The Valtecne SpA EBITDA history
YEAREBITDAYoY
4.91 MEUR-20.65%
6.19 MEUR+6.66%
5.80 MEUR+36.28%
4.26 MEUR+48.20%
2.87 MEUR+89.18%
1.52 MEUR-47.34%
2.88 MEUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valtecne SpA Stock analysis

What does Valtecne SpA do? Valtecne SpA produces precision-machined mechanical components for orthopedic and veterinary surgery, including cutting guides, pin pliers, femoral sizers, and tibial resection guides. The company also manufactures implantable devices such as femoral stems, femoral heads, stem collars, and tibial implants. These products are sold globally to medical device manufacturers and healthcare providers specializing in orthopedic and veterinary care. Valtecne SpA generates revenue through the sale of these high-precision surgical instruments and implantable devices to international medical markets. The company operates in the precision-machined sector, focusing on specialized instruments for orthopedic and veterinary surgery. Its product range includes both surgical tools like cutting guides and implantable components such as femoral stems. Valtecne SpA's global operations ensure its products reach medical device companies and clinics worldwide, supporting the production of advanced surgical solutions. Valtecne SpA's revenue model is based on manufacturing and selling precision-machined components for medical applications. The company's key products are surgical instruments and implantable devices used in orthopedic and veterinary procedures. By targeting medical device manufacturers and healthcare providers, Valtecne SpA secures contracts for its high-precision components, which are essential for surgical procedures and patient care. Valtecne SpA is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Valtecne SpA stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Valtecne SpA is 4.91 M EUR in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Valtecne SpA changed from 6.19 M EUR to 4.91 M EUR, representing a -20.65% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Valtecne SpA since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Valtecne SpA historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Valtecne SpA

All Key Metrics — Valtecne SpA